Global Veterinary Pain Management Market, By Product Type (Analgesics, Corticosteroids, and Alpha 2 Agonists), Drug Type (Branded and Generic), Mode of Purchase (Prescription Based and OTC), Animal Type (Companion Animal and Production Animal), Pain Source (Chronic Pain, Acute Pain, Post-Operative Pain, and Dental Pain), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Parenteral, Oral, and Topical), End User (Veterinary Hospitals, Veterinary Clinics, Pet Shops, Animal Farms, Academic & Research Institutes, and Others) - Industry Trends and Forecast to 2030.
Veterinary Pain Management Market Analysis and Insights
The global veterinary pain management market is expected to grow in the forecast year due to the rise in market players and the availability of advanced services and products. Along with this, manufacturers are engaged in R&D activity for launching novel drugs with their approval in the market. However, the high costs of pet care and the safety concerns for the drugs are expected to hamper the growth of the market in the forecast period. Increasing demand for non-conventional treatment approaches is expected to give opportunities to the market to enhance the treatment and diagnostic approaches. The growing demand for technological advancements in pain management is expected to boost the market’s growth. However, the resistance to the medications and limited availability of veterinarians is expected to challenge market growth.
Data Bridge Market Research analyzes that the global veterinary pain management market is expected to reach a value of USD 2,151,103.97 thousand by 2030, at a CAGR of 5.6% during the forecast period.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customization from 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Thousand, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Analgesics, Corticosteroids, and Alpha 2 Agonists), Drug Type (Branded and Generic), Mode of Purchase (Prescription Based and OTC), Animal Type (Companion Animal and Production Animal), Pain Source (Chronic Pain, Acute Pain, Post-Operative Pain, and Dental Pain), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Parenteral, Oral, and Topical), End User (Veterinary Hospitals, Veterinary Clinics, Pet Shops, Animal Farms, Academic & Research Institutes, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Poland, Denmark, Sweden, Norway, Finland, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Taiwan, Vietnam, rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, Oman, Qatar, Bahrain, rest of Middle East and Africa, Brazil, Argentina, and rest of South America
|
|
Market Players Covered
|
Dechra Pharmaceuticals PLC, Virbac, Norbrook, Durvet Animal Health Products, Bimeda, Inc., Inovet (A subsidiary of Orion Group), Chanelle Pharma, Zenex Animal Health India Private Ltd., Vetoquinol, Elanco, Merck & Co., Inc., Zoetis Services LLC, and Ceva Animal Health, LLC
|
Market Definition
The practice of reducing pain and discomfort in animals is referred to as "veterinary pain management", usually in the context of veterinary medicine. This subject focuses on recognizing and treating animal pain, whether it results from wounds, surgeries, chronic diseases, or other medical conditions. Veterinary pain management aims to enhance the health and quality of life of animals by minimizing or removing pain and its corresponding discomfort. The treatment is essential for moral reasons and the fact that untreated pain can negatively impact an animal's health and ability to recover from illnesses or accidents. Veterinarians are trained to assess, diagnose, and manage pain in animals to guarantee that animals receive effective and humane care. It is a vital component of contemporary veterinary care.
Veterinary Pain Management Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Increasing Pet Ownership
Pets are a popular choice among pet owners since they provide unconditional affection, companionship, and emotional support. Loneliness and stress levels can be decreased with the aid of pets. Children can gain a lot from having pets as they grow up, including lessons in compassion, empathy, and responsibility. In addition, having a pet might make people feel safe and comfortable.
It is getting easier for people and families to live with pets as more jobs and rental homes are becoming pet-friendly. The rise in pet ownership benefits both individuals and families in many ways, but it also puts pressure on the pet care sector, which includes veterinarian care, pet food, grooming, boarding, and pet supplies. While highlighting the significance of responsible pet ownership and animal welfare, meeting the requirements of this expanding community of pet owners creates opportunities for businesses and organizations in the pet care sector.
- Growing Incidences of Pet Diseases
It is more likely that pets will be exposed to other disease sources as more people adopt pets and bring them into their homes. Diseases are more likely to infect pets who contact with other animals, spend time outside, or travel. Urban areas can be favorable for the spread of some diseases as pets interact with a denser population of other animals and potentially infectious environmental elements. There has been an upsurge in pet border crossings, which increases the risk of diseases spreading to other areas. Pets can unintentionally help the spread of diseases that were previously unknown in some regions when traveling internationally. Therefore, the growing incidences of pet diseases in the region are expected to drive market growth.
Opportunity
- Rising Popularity of Non-Conventional Treatment Approaches
Alongside or as a substitute for conventional painkillers, pet owners and even some veterinarians are increasingly resorting to alternative therapies such as acupuncture, chiropractic treatment, herbal remedies, and physical therapy. Anecdotal proof of the efficacy of these unconventional methods, worries about possible drug side effects, a preference for holistic and natural treatments, and other factors all contribute to this shift in choice. The market for veterinary pain management faces both potential and problems as a result of the acceptance of non-traditional treatments, which indicates a greater understanding of the value of pain management for animals. On the plus side, it broadens the selection of possibilities for treating animal pain and provides alternatives for animals that might not respond well to conventional drugs or have contraindications. Thus, the rising popularity of non-conventional treatment approaches is expected to act as an opportunity for market growth.
Restraint/Challenge
- Strict Regulatory Guidelines
Clear and thorough regulatory criteria for veterinary pain management must be established, to encourage market expansion. These rules provide a framework for the creation, endorsement, and risk-free application of medications and other treatments for animal pain, which has numerous advantages for both industry participants and animal health. Regulations provide strict criteria for the effectiveness, safety, and quality of veterinary pain treatment medications. This gives veterinarians and pet owners the assurance that the therapies they provide are trustworthy and devoid of negative side effects.
Recent Developments
- In June 2023, Norbrook sponsored the International Society of Feline Medicine (ISFM) Congress in Dublin as a platinum sponsor. The International Society of Feline Medicine (ISFM) assists in providing veterinarians and nurses with the information they need to successfully treat cat health issues. Their annual Congress was held in Dublin, and Norbrook was well-represented there, with a strong emphasis on our main cat products, Thyronorm and Loxicom
- In May 2023, Virbac completed the purchase of all of the shares of its former distributor in the Czech Republic and Slovakia with the establishment of the 35th Virbac subsidiary. This acquisition is the result of years of hard effort by the teams led by Jakub Satrapa, the business's former owner and our future subsidiary's general manager. This is acknowledged by their inclusion in the Virbac clan. With the help of our new Virbac subsidiary, we will be able to more effectively and swiftly address the health needs of animals in Slovakia and the Czech Republic
Veterinary Pain Management Market Scope
The global veterinary pain management market is segmented into eight notable segments based on product type, drug type, mode of purchase, animal type, pain source, dosage, route of administration, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Product Type
- Analgesics
- Corticosteroids
- Alpha-2 Agonists
On the basis of product type, the market is segmented into analgesics, corticosteroids, and alpha-2 agonists.
Drug Type
- Branded
- Generic
On the basis of drug type, the market is segmented into branded and generic.
Mode of Purchase
- Prescription Based
- OTC
On the basis of mode of purchase, the market is segmented into prescription based and OTC.
Animal Type
- Companion Animal
- Production Animal
On the basis of animal type, the is segmented into companion animal and production animal.
Pain Source
- Chronic Pain
- Acute Pain
- Post-Operative Pain
- Dental Pain
On the basis of pain source, the market is segmented into chronic pain, acute pain, post-operative pain, and dental pain.
Dosage
- Solid
- Liquid
- Semi-Solid
On the basis of dosage, the market is segmented into solid, liquid, and semi-solid.
Route of Administration
- Parenteral
- Oral
- Topical
On the basis of route of administration, the market is segmented into parenteral, oral, and topical.
End User
- Veterinary Hospitals
- Veterinary Clinics
- Pet Shops
- Animal Farms
- Academic & Research Institutes
- Others
On the basis of end user, the market is segmented into veterinary hospitals, veterinary clinics, pet shops, animal farms, academic & research institutes, and others.
Veterinary Pain Management Market Regional Analysis/Insights
The global veterinary pain management market is segmented into eight notable segments based on product type, drug type, mode of purchase, animal type, pain source, dosage, route of administration, and end user.
The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Poland, Denmark, Sweden, Norway, Finland, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Taiwan, Vietnam, rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, Oman, Qatar, Bahrain, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to the increasing investment in veterinary care, which is expected to boost the market growth. The U.S. is expected to dominate the North America region due to the strong presence of key players. Germany is expected to dominate Europe region due to the increasing demand for emerging markets and expansion. China is expected to dominate the Asia-Pacific region due to increasing pet ownership among the population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Veterinary Pain Management Market Share Analysis
The global veterinary pain management market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the key players operating in the global veterinary pain management market are Dechra Pharmaceuticals PLC, Virbac, Norbrook, Durvet Animal Health Products, Bimeda, Inc., Inovet (A subsidiary of Orion Group), Chanelle Pharma, Zenex Animal Health India Private Ltd., Vetoquinol, Elanco, Merck & Co., Inc., Zoetis Services LLC, and Ceva Animal Health, LLC among others.
SKU-